Exploiting the Body’s Immune System to Treat a Broad […]
Location: United States, California, Redwood City
Total raised: $147M
Investors 3
| Date | Name | Website |
| - | LAV | lavfund.co... |
| - | Aisling Ca... | aislingcap... |
| - | GV | gv.com |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 31.08.2017 | Series C | $67M | GV |
| 11.02.2016 | Series C | $50M | - |
| 28.05.2014 | Series B | $30M | - |
Mentions in press and media 14
| Date | Title | Description |
| 27.01.2021 | ARMO Emerges from Stealth with $4.5 Million to Infuse Visibility, Control and Security into Every Cloud-Native Workload USA - English USA - English | |
| 15.05.2018 | Beth Seidenberg of Kleiner Perkins is starting her own fund | Beth Seidenberg joined Kleiner Perkins 13 years ago to focus on life sciences for the storied venture firm. Now, according to a Recode report, she’s heading off to start her own life sciences venture fund in L.A. where she lives. We reached... |
| 26.01.2018 | In post-IPO party, Nasdaq’s newcomers Armo, Menlo and Solid soar within hours of listing | Three newly-minted biotech stocks are leaping in value just days after listing on the Nasdaq, sending a clear signal to industry that investors’ insatiable appetite will carry into 2018. Although there’s no sign of this ac... |
| 18.01.2018 | Term Sheet — Thursday, January 18 | BREAKING TRADITION Good morning, Term Sheet readers. Paid Content You can't secure what you can't see From ExtraHop Ripple, the fintech startup behind the XRP coin, didn’t invest directly in the round. Rather, the company’s executives Stefa... |
| 03.01.2018 | Armo Biosciences Files for IPO | Armo BioSciences, Inc., a Redwood City, Calif.-based late-stage immuno-oncology company, has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of... |
| 02.01.2018 | Term Sheet — Tuesday, January 2 | UBER’S RESET Happy New Year, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop UBER’S BIG DAY: SoftBank agreed to invest more than $7 billion in Uber for a 15% stake in the tech giant. According to me... |
| 01.12.2017 | Teva boots its R&D chief; Ironwood grows the C-suite and Intercept taps new EVP of research | Michael Hayden → In the first major C-suite overhaul under new CEO Kåre Schultz, troubled Teva is parting ways with R&D chief Michael Hayden, Global Specialty Medicines head Rob Koremans, and Global Generic Medicines ... |
| 01.09.2017 | Term Sheet — Friday, September 1 | HOT TAKES Thank you for your thoughtful responses to yesterday’s question: What industry do you think blockchain will affect or disrupt that no one is talking about? Paid Content What you need to know about growing cyberattacks From ExtraHo... |
| 31.08.2017 | ARMO Biosciences Receives $67M | REDWOOD CITY, CA, ARMO BioSciences, a late-stage immuno-oncology company, today announced the successful completion of a $67 million Series C-1 private financing led by new investor Qiming Venture Partners. >> Click here for more f... |
| 31.08.2017 | Celgene Joins $67M Series C-1 for Armo Biosciences | ARMO BioSciences, Inc., a late-stage immuno-oncology company, today announced the successful completion of a $67 million Series C-1 private financing led by new investor Qiming Venture Partners. Additional new investors Decheng Capital, Seq... |
Show more